good.is — The tech sector faces a Big Pharma kind of problem. Drug-makers have plenty of incentive to cure first-world ailments because those customers can pay big bucks for even non-vital drugs-Viagra being the classic example-but there's scant profit in ending diseases that only affect the poor, like polio.